$CPB

Goldfish crackers are finally getting a gluten-free version

Campbell Soup’s Goldfish brand will launch certified gluten-free cheese crackers nationwide in November 2026, according to Campbell’s. The company said it responded to consumer requests and aimed to match Goldfish taste and texture. The move follows gluten-free launches by Pepperidge Farm and Nabisco, and comes as Campbell’s snacks business has stabilized but Goldfish is still down 1% to 2% after earlier declines, per its June earnings call.

Original reporting
Published Aug 12, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 4:25 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Goldfish crackers are finally getting a gluten-free version — source image
Decision brief

The 30-second read

$CPBBullishLow
01

Why it matters

The gluten-free Goldfish launch addresses consumer demand and fills a portfolio gap, aligning with management’s margin-focused framing of Goldfish as the biggest and most profitable snacks piece.

02

Market read

Traders get a concrete product-timing catalyst for Campbell’s Goldfish franchise, but no financial targets or near-term earnings impact are provided.

03

What to watch

The article does not quantify expected sales, pricing, or cannibalization versus existing Goldfish variants, which are key to margin impact.

Relevance 5/10Novelty 5/10Timing: product hits retailers in November 2026

Background

Goldfish is part of Campbell’s snacks business; the article notes stabilization after earlier declines and management’s preference for fewer, bigger innovations.

Company-level read

Ticker impact

$CPBBullishMedium confidence
Context

Campbell’s is cited calling Goldfish’s gluten-free launch one of the most requested innovations in the brand’s history.

Expected impact

Likely limited near-term impact; any upside would be gradual as distribution and sales ramp in late 2026.

Evidence & confidence

The news is a product launch with a stated November 2026 timing, and management frames Goldfish as key to margins, but there are no quantified revenue or margin targets.

Market effects

Highlights continued mainstreaming of gluten-free snacks, reinforcing competitive pressure on packaged snack brands.

Retail rollout is described as nationwide in the US, implying broad shelf-space competition.

Uses global gluten-free/dietary-condition demand stats, but the launch is US-focused.

Counterpoint

Gluten-free is a crowded category; without evidence of incremental share gains, the launch may be more defensive than value-accretive.

Key entities

  • Campbell Soup Company

    Parent company referenced via executives discussing Goldfish’s role in margins and innovation strategy.

  • Goldfish Crackers

    Campbell’s snack brand launching a certified gluten-free cheese cracker version in November 2026.

  • Pepperidge Farm

    Mentioned as having introduced gluten-free options in 2020, providing competitive context.

  • Mondelēz International

    Mentioned as having launched gluten-free Cheez-It earlier this year, indicating peer momentum.

Related articles

$UTZMed

Family-owned companies have big appetites for US snack M&A

Utz UTZ.N agreed to be taken private by Germany’s Intersnack Group, with Utz’s founding families, in a deal valued at nearly $3 billion, the first U.S. acquisition for Intersnack. The article cites other family-led snack deals including Ferrero’s purchases of WK Kellogg and Power Crunch, and Mars’s $36 billion take-private of Kellanova. It notes valuation multiples and potential targets.

$CPBLow

Top analysts reset Campbell’s stock amid major challenges

Between June 1-5, five Wall Street analysts adjusted Campbell’s (CPB) outlook ahead of its June 8 Q3 fiscal 2026 results, according to Benzinga. Targets were cut by Morgan Stanley ($21 from $23), Bernstein ($19 from $21, downgraded to underperform), UBS ($19 from $20), and Evercore ISI ($24 from $26). Campbell reported adjusted EPS of 50 cents (+1 penny YoY, -32%), net sales down 4% to $2.4B, and margin pressure from tariffs; snacks margins fell ~400 bps.

$CPBMedAI 8/10

Campbell's Q3 Earnings Call Highlights

Campbell’s executives said incentive compensation reset and higher marketing are expected to add about a $40 million impact next year, while the company plans to accelerate savings from a previously announced $100 million SG&A reduction and other productivity initiatives. Snacks margins improved sequentially (EBITDA margin ~7% to ~10%) but remain ~400 bps below last year. Q4 net sales are expected flat to slightly up; adjusted EPS likely around $2.20 or below.

$MRVLMed

Index rebalancing can deliver bargains. Here’s how to find them

S&P 500 index managers announced quarterly changes: Marvell Technology and Flex Ltd. will join the index, while Pool Corp. and Campbell’s Co. will be removed. The article says added stocks have averaged about +255% over the past year versus -36% for deletions. It cites Research Affiliates’ 2024 paper: deletions outperformed by over 5% annually over the next five years.

$MUMed

ASX set to rise, Wall Street steadies as tech stocks rebound

Wall Street steadied after last week’s sell-off, with the S&P 500 up 0.3% (Nasdaq +0.9%, Dow -0.2%). AI-linked chip and memory stocks rebounded: Micron rose 9.9% after a 13.3% Friday drop; Marvell gained 9.6% after being approved for the S&P 500. ASX futures pointed to a 0.3% open gain. Oil rose on Israel-Iran strikes, with Brent settling at $94.25 (+1.2%).